Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlinear system-guided continuous-time generalization for cross-aircraft engine state monitoring.

ISA transactions·2026
Same author

Navigation System-Assisted vs Freehand Cannulated Screw Fixation for Femoral Neck Fractures: Protocol for a Multicenter Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Early replication fragile sites are associated with cancer-related CNVs and SNVs in human embryonic stem cells.

Stem cell reports·2026
Same author

Melatonin Rescues Enamel Defects Induced by Maternal Circadian Disruption via Targeting the BMAL1-JNK3 Axis.

International dental journal·2026
Same author

Natural occurrence of ustiloxin A and D in rice in China.

Mycotoxin research·2026
Same author

Risk factors for atherosclerotic plaque formation in MASLD patients: insights from cross-sectional and Mendelian randomization analyses.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026

Related Experiment Video

Updated: Jun 24, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Propofol and ketamine-induced anesthetic depth-dependent decrease of CaMKII phosphorylation levels in rat hippocampus

Xu Cui1, Junfa Li, Tianzuo Li

  • 1Department of Anesthesiology, Capital Medical University Affiliated Beijing Tongren Hospital, Beijing, China.

Journal of Neurosurgical Anesthesiology
|March 20, 2009
PubMed
Summary
This summary is machine-generated.

Propofol and ketamine decrease CaMKII phosphorylation in rats, impacting brain function during anesthesia. This effect is dependent on anesthetic depth and drug dosage, with levels returning to normal after 240 minutes.

More Related Videos

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

Related Experiment Videos

Last Updated: Jun 24, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Molecular Biology

Background:

  • Ca/calmodulin-dependent protein kinase II (CaMKII) activation via autophosphorylation at threonine 286 is crucial for neuronal excitability and neurotransmission.
  • Propofol and ketamine, common anesthetics, influence intracellular calcium levels through NMDA receptors or voltage-dependent calcium channels, but with distinct mechanisms.

Purpose of the Study:

  • To investigate the effects of propofol and ketamine on CaMKII total protein and phosphorylated CaMKII (p-CaMKII) levels in rat brains.
  • To determine if these effects are dependent on anesthetic depth, drug dosage, and brain region.

Main Methods:

  • Rats were administered varying doses of propofol and ketamine via intraperitoneal injection.
  • Brain tissue (hippocampus and frontal cortex) was analyzed for CaMKII total protein and p-CaMKII levels at different time points (5, 30, 60, 240 minutes) post-injection.
  • Immunostaining was used to confirm p-CaMKII depression in specific brain regions.

Main Results:

  • Both propofol and ketamine reduced p-CaMKII levels in a manner dependent on anesthetic depth, without affecting total CaMKII protein.
  • Ketamine exhibited a dose-dependent depression of p-CaMKII (50, 100, 150 mg/kg).
  • p-CaMKII levels decreased significantly starting at 5 minutes post-propofol (100 mg/kg) and at 30 minutes post-ketamine (100 mg/kg) in the hippocampus, with frontal cortex showing effects at 5 minutes for both drugs.

Conclusions:

  • Decreased p-CaMKII levels correlate with anesthetic depth achieved by propofol and ketamine.
  • These findings suggest a potential mechanism linking propofol and ketamine's effects on central nervous system function and their clinical anesthetic properties to alterations in CaMKII phosphorylation.